2024-04-26-上交所科创板-United_Imaging_Healthcare_2023_ESG_Report_99页_43mb

2023 Environmental, Social and Governance Report Summary - Shanghai United Imaging Healthcare Co., Ltd.

Core Content Overview

Shanghai United Imaging Healthcare Co., Ltd. (UIH) released its 2023 Environmental, Social and Governance (ESG) Report, emphasizing its commitment to sustainable development, social responsibility, and corporate governance. The report outlines the company's strategies and achievements across multiple dimensions, including environmental sustainability, social contributions, and governance practices, while also highlighting its global presence and innovation in the medical technology sector.

Main Sections and Key Points

1. Sustainable Development Management

• Mission and Vision: UIH is dedicated to the mission of "To Bring Equal Healthcare for All" and the vision of "Leading Healthcare Innovation".
• ESG Integration: The company integrates ESG principles into its strategies and operations, ensuring that environmental, social, and governance considerations are central to its business model.
• ESG Governance Structure:
  • The Board of Directors oversees ESG strategic planning and regularly evaluates ESG performance.
  • The Strategy and Social Responsibility Committee is responsible for researching, proposing, and supervising ESG decisions and policies, as well as coordinating ESG report reviews and providing regular updates to the Board.
• ESG Performance Indicators:
  • Environmental: Focus on carbon reduction, energy efficiency, and waste management.
  • Social: Commitment to employee growth, community engagement, and medical accessibility.
  • Governance: Emphasis on compliance, transparency, and responsible operations.

2. Healthcare Accessibility and Universalizing Welfare

• Global Reach: UIH's products are available in 65+ countries and regions, with a focus on 30+ countries facing medical shortages.
• County Hospital Collaboration: UIH supports county hospitals through intelligent medical solutions and integrated disease-specific systems, enhancing rural healthcare access.
• Medical Equality: The company actively promotes global medical equality, providing aid to over 30 countries and all provinces in China during the pandemic.

3. Technological Innovation and Industry Advancement

• Innovation Matrix: UIH has developed a diversified innovation matrix, focusing on imaging technology, digital solutions, and precision medicine.
• International Collaboration: The company collaborates with top universities and research institutions globally, including the establishment of the first international multi-center research cooperation platform.
• Product Launches: In 2023, UIH launched nearly 120 products, achieving operating revenue exceeding 10 billion RMB.

4. Lean Quality Management

• Product Quality: UIH ensures high-quality products through rigorous quality audits, achieving a 100% pass rate.
• Service Excellence: The company emphasizes building quality service and implementing responsible purchasing.
• Compliance: UIH maintains a 100% environmental compliance rate and prevents data risks through robust compliance measures.

5. People-oriented Approach and Employee Growth

• Employee Support: UIH values its employees as its most prized asset, providing diverse training programs and career development opportunities.
• Diversity and Inclusion: The company fosters a diverse and inclusive workplace, with employees from over 10 countries.
• Employee Satisfaction: UIH ensures employee rights and interests, and 100% coverage of anti-corruption training for all levels.

6. Public Welfare and Charity

• Charitable Activities: UIH actively engages in public welfare and charity, including donations of medical equipment to disaster areas.
• Community Engagement: The company promotes medical knowledge popularization and supports social projects to fulfill its social responsibility.

7. Green Transformation and Carbon Reduction

• Environmental Goals: UIH aims to reduce Scope 1 and Scope 2 carbon emission intensity by 50% by 2035, using 2023 as the baseline.
• Green Initiatives: The company implements energy-saving measures, green production, and eco-friendly operations.
• Environmental Performance: UIH reports 75,875.97 tCO2e in Scope 1 and 2 emissions, with an energy consumption intensity of 24.58 GJ/million RMB.

Key Performance Indicators in 2023

Economic Performance

• Operating Revenue: RMB 11.41 billion, a year-on-year increase of 23.52%.
• Net Profit Attributable to Shareholders: RMB 1.97 billion, a year-on-year increase of 19.21%.
• R&D Investment: RMB 1.92 billion, with 16.81% of revenue allocated to R&D.
• Net Profit After Parental Profit: RMB 1.67 billion, a year-on-year increase of 25.38%.

Social Performance

• Patents and IP: 9,933 patents and IP applications, with 5,160 cumulative patents.
• Products Launched: 110+ products certified and launched, covering 65+ countries.
• Employment: Provided employment for 7,440 people worldwide, with a 100% labor contract signing rate.
• Employee Training: 45,888 hours of training, with 100% coverage of anti-corruption training.
• Public Welfare Donations: RMB 8.49 million, including a donation of over RMB 3 million to disaster areas via the Gansu Red Cross.

Environmental Performance

• Greenhouse Gas Emissions: 75,875.97 tCO2e in Scope 1 and 2, with a carbon emission intensity of 6.65 tCO2e/million RMB.
• Water Consumption: 266,099.00 T, with a water consumption intensity of 23.32 T/million RMB.
• Energy Consumption: 280,489.24 GJ, with an energy consumption intensity of 24.58 GJ/million RMB.
• Environmental Compliance: 100% compliance rate.

Company Profile

• Established in 2011, UIH is a leading high-end medical device company with its headquarters in Shanghai.
• Global Presence: UIH has established regional headquarters and R&D centers in the US, Malaysia, UAE, and Poland, and production facilities in Shanghai, Changzhou, Wuhan, and Houston.
• Product Portfolio: Launched nearly 120 products, used by thousands of medical institutions in over 60 countries.
• Global Collaboration: Deeply involved with global universities, hospitals, and industrial partners to advance precision medicine and scientific research.

Awards and Recognitions

• Innovation Awards: Recognized for medical innovation, including the 2023 Forbes China Top 50 Innovative Companies and the 2023 STAR Market Leading Enterprises in Hard Technology.
• ESG Excellence: Awarded as the 2023 Best ESG Listed Company on the Science and Technology Innovation Board and China's Top 100 Listed Companies in ESG.
• Corporate Influence: Recognized in healthcare industry rankings, including the 2023 Future of Healthcare 100 Pengcheng Award and 2023 Sina Finance Golden Unicorn Most Valuable Brand Medical Company.

Conclusion

UIH continues to drive healthcare innovation, global accessibility, and sustainable development. By integrating ESG principles into its operations, the company not only enhances its corporate social responsibility but also strengthens its global competitiveness and environmental stewardship, positioning itself as a leader in the medical technology industry.